Depression breakthrough

Eli Lilly which makes Prozac depression pills, said a study of the experimental Cymbalta anti-depressant showed continuing treatment with the drug after symptoms disappear results in fewer relapses.

About 80% of patients taking daily doses of Cymbalta remained free of emotional and physical symptoms of depression in the 38-week study funded by Lilly, compared with those who stopped when they felt better.